1. Short title This Act may be cited as the Drug-Free Indian Health Service Act of 2017 . 2. Mandatory Random Drug Testing of Certain Employees of Indian Health Service (a) Regulations (1) In General Not later than 90 days after the date of the enactment of this Act, the Secretary shall promulgate such regulations as are necessary to implement a mandatory random drug testing program for covered employees of the Indian Health Service. Except as otherwise provided for in this section, the Secretary shall promulgate such regulations in accordance with the following: (A) The guidelines promulgated on November 25, 2008, titled Mandatory Guidelines for Federal Workplace Drug Testing (73 Fed. Reg. 71858). (B) The regulations promulgated under section 264(c) of the Health Insurance Portability and Accountability Act of 1996 ( 42 U.S.C. 1320d–2 note). (2) Testing of Certain Drugs In carrying out the program required under paragraph (1), the Secretary shall ensure that each covered employee is tested not less than once per year for each of the following drugs: (A) Marijuana. (B) Cocaine. (C) Opiates. (D) Amphetamines. (E) Methamphetamine. (F) Phencyclidine. (b) Notice of Mandatory Random Drug Testing Program Not less than 90 days before implementing the program required under subsection (a), the Secretary shall provide written notice to all covered employees that— (1) a mandatory random drug testing program will be implemented; and (2) covered employees will have the opportunity, and reasonable time, to submit medical documentation of lawful use of a drug listed under subsection (a)(2). (c) Notification of Selection The Secretary shall— (1) notify a covered employee selected for random drug testing under this section on the same day of, but prior to, such testing